Altimmune, Inc. (ALT) stock
ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.53−0.03 (-1.92%)
Close on Nov 17, 2026Market cap $297.61MP/E –Yield –
Altimmune market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Altimmune's market cap was $375.34M on Nov 11, 2026, against $502.85M a year earlier. Over the last 5 years it ranged from $126.90M to $1.02B, with a median of $422.59M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $375.34M | +8.8% |
| 2025 | Dec 31, 2025 | $345.11M | -32.7% |
| 2024 | Dec 31, 2024 | $512.81M | -13.8% |
| 2023 | Dec 29, 2023 | $594.66M | -26.5% |
| 2022 | Dec 30, 2022 | $808.71M | +122.4% |
| 2021 | Dec 31, 2021 | $363.68M | -2.5% |
| 2020 | Dec 31, 2020 | $373.06M | +1186.9% |
| 2019 | Dec 31, 2019 | $28.99M | +715.5% |
| 2018 | Dec 31, 2018 | $3.55M | -88.6% |
| 2017 | Dec 29, 2017 | $31.10M | -86.6% |
| 2016 | Dec 30, 2016 | $231.32M | -36.4% |
| 2015 | Feb 20, 2015 | $363.49M | +31.4% |
| 2013 | May 28, 2013 | $276.70M | +5.5% |
| 2012 | Dec 31, 2012 | $262.36M | +4.2% |
| 2011 | Dec 30, 2011 | $251.73M | – |
See a number that looks wrong?